Advances in the management of retinopathy of prematurity

References

• Jacobson L, Fennell E, Broberger U et al. Children with blindness due to retinopathy of prematurity – a population based study perinatal data, neurological and ophthalmalogical outcome. Dev. Med. Child Neurol.40, 155–159 (1998).
   PubMedGoogle Scholar
• Rahi JS, Cable N; British Childhood Visual Impairment Study Group. Severe visual impairment and blindness in children in the UK. Lancet362, 1359–1365 (2003).
   PubMed Web of Science ®Google Scholar
• Gilbert C, Rabi J, Eckstein M et al. Retinopathy of prematurity in middle income countries. Lancet350, 12–14 (1997).
   PubMed Web of Science ®Google Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics116(1), 15–23 (2005).
   PubMed Web of Science ®Google Scholar
• Schaffer DB, Palmer EA, Plotsky DF et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology100, 230–237 (1993).
   PubMed Web of Science ®Google Scholar
• Wallace DK, Kylstra JA, Phillips SJ, Hall JG. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J. AAPOS4, 342–347 (2000).
   Google Scholar
• Flynn JT, Bancalari E, Snyder ES et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N. Engl. J. Med.326, 1050–1054 (1992).
   PubMed Web of Science ®Google Scholar
• Brown DR, Biglan AW, Stretavsky MMA. Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia. J. Pediatr. Ophthalmol. Strabismus27, 268–271 (1990).
   PubMedGoogle Scholar
• Hammer ME, Mullen PW. Logistic analysis of risk factors in acute retinopathy of prematurity. Am. J. Ophthalmol.102, 1–6 (1986).
   PubMed Web of Science ®Google Scholar
• Darlow BA, Horwood LJ. Retinopathy of prematurity: risk factors in a prospective population-based study. Paediatr. Perinat. Epidemiol.6, 62–80 (1992).
   PubMedGoogle Scholar
• Hutcheson KA, Paluru PC, Bernstein SL et al. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol. Vis.11, 501–508 (2005).
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N. Pathologic Basis of Disease, 7th Ed. Robbins and Cotran (Eds).
   Google Scholar
• Lutty GA, Chan-Ling T, Phelps DL et al. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery. Mol. Vis.12, 532–580 (2006).
   PubMedGoogle Scholar
• Pierce EA, Foley ED, Smith LEH. Regulation of retinal vascular endothelial growth factor by hyperoxia and hypoxia: a possible etiology for retinopathy of prematurity. Inv. Ophthalmol. Vis. Sci.36, S871 (1995).
   PubMed Web of Science ®Google Scholar
• Smith LE, Shen W, Perruzzi C et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med.5, 1390–1395 (1999).
   PubMed Web of Science ®Google Scholar
• Forsythe JA, Jiang BH, Iyer N et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol.16, 4604–4613 (1996).
   PubMed Web of Science ®Google Scholar
• Smith LE, Kopchick JJ, Chen W et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science276, 1706–1709 (1997).
   PubMed Web of Science ®Google Scholar
• The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch. Ophthalmol.102, 1130–1134 (1984).
   PubMed Web of Science ®Google Scholar
• An International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch. Ophthalmol.123, 991–999 (2005).
   PubMed Web of Science ®Google Scholar
• Joshi MM, Trese MT, Capone A Jr. Optical coherence tomography findings in stage 4A retinopathy of prematurity: a theory for visual variability. Ophthalmology113(4), 657–660 (2006).
   PubMed Web of Science ®Google Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch. Ophthalmol.106, 471–479 (1988).
   PubMed Web of Science ®Google Scholar
• Hardy RJ, Palmer EA, Dobson V et al.; for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Risk analysis of prethreshold retinopathy of prematurity. Arch. Ophthalmol.121, 1697–1701 (2003).
   PubMedGoogle Scholar
• Flynn JT, Chan-Ling T. Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease. Am. J. Ophthalmol.142(1), 46–59 (2006).
   PubMed Web of Science ®Google Scholar
• Gilbert C, Fielder A, Gordillo L et al; International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics115(5), E518–E525 (2005).
   PubMed Web of Science ®Google Scholar
• Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics117, 572–576 (2006). Erratum published in Pediatrics118, 1324 (2006).
   PubMed Web of Science ®Google Scholar
• Schwartz SD, Harrison SA, Ferrone PJ, Trese MT. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology107, 25–28 (2000).
   PubMed Web of Science ®Google Scholar
• Ells AL, Holmes JM, Astle WF et al. Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology110(11), 2113–2117 (2003).
   PubMed Web of Science ®Google Scholar
• Chiang MF, Keenan JD, Starren J et al. Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch. Ophthalmol.124(3), 322–327 (2006).
   PubMedGoogle Scholar
• Wallace DK, Jomier J, Aylward SR, Landers MB. Computer-automated quantification of plus disease in retinopathy of prematurity. J. AAPOS7(2), 126–130 (2003).
   PubMed Web of Science ®Google Scholar
• The photographic screening for retinopathy of prematurity study (PHOTO-ROP), study design and baseline characteristics of enrolled patients. Retina26(7 Suppl.), S4–S10 (2006).
   PubMed Web of Science ®Google Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch. Ophthalmol.106, 471–479 (1988).
   PubMed Web of Science ®Google Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Arch. Ophthalmol.112, 903–912 (1994).
   PubMed Web of Science ®Google Scholar
• Palmer EA, Hardy RJ, Dobson V et al. Cryotherapy for Retinopathy of Prematurity Cooperative Group. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch. Ophthalmol.123(3), 311–338 (2005).
   PubMed Web of Science ®Google Scholar
• Quinn GE, Dobson VE, Repka MX et al. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Development of myopia in infants with birth weights less than 1251 grams. Ophthalmology99, 329–340 (1992).
   PubMed Web of Science ®Google Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Effect of retinal ablative therapy for threshold retinopathy of prematurity. Results of Goldmann perimetry at the age of 10 years. Arch. Ophthalmol.119, 1120–1125 (2001).
   PubMedGoogle Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. Strabismus in premature infants in the first year of life. Arch. Ophthalmol.116, 329–333 (1998).
   PubMedGoogle Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g. Arch. Ophthalmol.120, 595–599 (2002).
   PubMed Web of Science ®Google Scholar
• Jaccoma EH, Conway BP, Campochiaro PA. Cryotherapy causes extensive breakdown of the blood-retinal barrier. A comparison with argon laser photocoagulation. Arch. Ophthalmol.103(11), 1728–1730 (1985).
   PubMedGoogle Scholar
• McNamara JA, Tasman W, Vander JF, Brown GC. Diode laser photocoagulation for retinopathy of prematurity: preliminary results. Arch. Ophthalmol.110, 1714–1716 (1992).
   PubMedGoogle Scholar
• Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity: a randomized study. Ophthalmology100, 238–244 (1993).
   PubMed Web of Science ®Google Scholar
• White JE, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome. J. Pediatr. Ophthalmol. Strabismus34, 83–87 (1997).
   PubMedGoogle Scholar
• Paysse EA, Lindsey JL, Coats DK, Contant CF Jr, Steinkuller PG.Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity. J. AAPOS3(4), 234–240 (1999).
   PubMed Web of Science ®Google Scholar
• Fleming TN, Runge PE, Charles ST. Diode laser photocoagulation for prethreshold, posterior retinopathy of prematurity. Am. J. Ophthalmology114, 589 (1992).
   PubMedGoogle Scholar
• Good WV, Hardy RJ. The multicenter study of early treatment for retinopathy of prematurity. Ophthalmology108, 1013–1014 (2001).
   PubMed Web of Science ®Google Scholar
• Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans. Am. Ophthalmol. Soc.102, 233–248; discussion 248–250 (2004).
   PubMedGoogle Scholar
• Good WV. The Early Treatment for Retinopathy of Prematurity Study: structural findings at age 2 years. Br. J. Ophthalmol.90(11), 1378–1382 (2006).
   PubMed Web of Science ®Google Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch. Ophthalmol.121, 1684–1696 (2003).
   PubMed Web of Science ®Google Scholar
• Haigh PM, Malcolm L Chiswick ML, O’Donoghuea EP. General anesthesia with endotracheal intubation for cryotherapy for retinopathy of prematurity. Eur. J. Ophthalmol.5(3), 187–191 (1995).
   PubMedGoogle Scholar
• Cravero JP, Blike GT, Beach M et al. Pediatric Sedation Research Consortium. Incidence and nature of adverse events during pediatric sedation/anesthesia for procedures outside the operating room: report from the Pediatric Sedation Research Consortium. Pediatrics118(3), 1087–1096 (2006).
   PubMed Web of Science ®Google Scholar
• Chen SD, Sundaram V, Wilkinson A, Patel CK. Variation in anaesthesia for the laser treatment of retinopathy of prematurity – a survey of ophthalmologists in the UK. Eye Jul 28 (Epub ahead of print) (2006).
   Google Scholar
• Wallace DK. Retinopathy of prematurity survey results. J. AAPOS2(2), 65–66 (1998).
   PubMedGoogle Scholar
• Freeman HM, Hawkins WR, Schepens CL. Anterior segment necrosis. An experimental study. Arch. Ophthalmol.75, 644–650 (1966).
   PubMedGoogle Scholar
• Lambert SR, Capone A Jr, Cingle KA, Drack AV. Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity. Am. J. Ophthalmol.129(5), 585–591 (2000).
   PubMed Web of Science ®Google Scholar
• Shaikh S, Capone A Jr. Inadvertent skip areas in treatment of zone 1 retinopathy of prematurity. Retina23(1), 128–131 (2003).
   PubMedGoogle Scholar
• Löfqvist C, Andersson E, Sigurdsson J et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch. Ophthalmol.124(12), 1711–1718 (2006).
   PubMedGoogle Scholar
• Seiberth V, Linderkamp O, Vardarli I. Transscleral vs transpupillary diode laser photocoagulation for the treatment of threshold retinopathy of prematurity. Arch. Ophthalmol.115, 1270–1275 (1997).
   PubMedGoogle Scholar
• Simons BD, Wilson MC, Hertle RW, Schaefer DB. Bilateral hyphemas and cataracts after diode laser retinal photoablation for retinopathy of prematurity. J. Pediatr. Ophthalmol. Strabismus35, 185–187 (1998).
   PubMedGoogle Scholar
• Rundle P, McGinnity FG. Bilateral hyphaema following diode laser for retinopathy of prematurity. Br. J. Ophthalmol.79, 1055–1056 (1995).
   PubMedGoogle Scholar
• Noonan CP, Clark DI. Acute serous detachment with argon laser photocoagulation in retinopathy of prematurity. J. AAPOS1, 183–184 (1997).
   PubMedGoogle Scholar
• Kaiser RS, Trese MT. Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch. Ophthalmol.119, 615–617 (2001).
   PubMed Web of Science ®Google Scholar
• Irvine WD, Smiddy WE, Nicholson DH. Corneal and iris burns with the laser indirect ophthalmoscope. Am. J. Ophthalmol.110, 311–313 (1990).
   PubMedGoogle Scholar
• Christiansen SP, Bradford JD. Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am. J. Ophthalmol.119, 175–180 (1995).
   PubMedGoogle Scholar
• Paysse EA, Miller A, Brady McCreery KM, Coats DK. Acquired cataracts after diode laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology109(9), 1662–1665 (2002).
   PubMedGoogle Scholar
• VanderVeen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J. AAPOS10(5), 445–448 (2006).
   PubMed Web of Science ®Google Scholar
• Kaiser RS, Trese MT. Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch. Ophthalmol.119, 615–617 (2001).
   PubMed Web of Science ®Google Scholar
• Capone A Jr, Drack AV. Transient lens changes after diode laser retinal photoablation for retinopathy of prematurity. Am. J. Ophthalmol.118, 533–535 (1994).
   PubMed Web of Science ®Google Scholar
• Trigler L, Weaver RG Jr, O’Neil JW, Barondes MJ, Freedman SF. Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity. J. AAPOS9(1), 17–21 (2005).
   PubMedGoogle Scholar
• Park P, Eagle RC Jr, Tasman WS. Diode laser photocoagulation for retinopathy of prematurity: a histopathologic study. Ophthalmic Surg. Lasers32(1), 63–66 (2001).
   PubMedGoogle Scholar
• Repka MX, Tung B, Good WV et al. Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP). Arch. Ophthalmol.124(1), 24–30 (2006).
   PubMed Web of Science ®Google Scholar
• Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology108(11), 2068–2070 (2001).
   PubMed Web of Science ®Google Scholar
• Hartnett ME, Maguluri S, Thompson HW, McColm JR. Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Retina24(5), 753–757 (2004).
   PubMed Web of Science ®Google Scholar
• Lakhanpal RR, Sun RL, Albini TA, Holz ER. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology112(9), 1569–1573 (2005).
   PubMed Web of Science ®Google Scholar
• Lakhanpal RR, Sun RL, Albini TA, Coffee R, Coats DK, Holz ER. Visual outcomes after 3-port lens-sparing vitrectomy in stage 4 retinopathy of prematurity. Arch. Ophthalmol.124, 675–679 (2006).
   PubMedGoogle Scholar
• Lakhanpal RR, Sun RL, Albini TA, Holz ER. Anatomical success rate after primary three-port lens-sparing vitrectomy in stage 5 retinopathy of prematurity. Retina26(7), 724–728 (2006).
   PubMedGoogle Scholar
• Lakhanpal RR, Fortun JA, Chan-Kai B, Holz ER. Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity. Retina26(7), 736–740 (2006).
   PubMed Web of Science ®Google Scholar
• Cross KW. Cost of preventing retrolental fibroplasia? Lancet2(7835), 954–956 (1973).
   PubMed Web of Science ®Google Scholar
• Chow LC, Wright KW, Sola A; CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics111(2), 339–345 (2003).
   PubMed Web of Science ®Google Scholar
• York JR, Landers S, Kirby RS et al. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J. Perinatol.24(2), 82–87 (2004).
   PubMedGoogle Scholar
• Wallace DK. Oxygen saturation levels and retinopathy of prematurity – are we on target?. J. AAPOS10(5), 382–383 (2006).
   PubMedGoogle Scholar
• Cole CH, Wright KW, Tarnow-Mordi W et al. Resolving our uncertainty about oxygen therapy. Pediatrics112, 1415–1419 (2003).
   PubMed Web of Science ®Google Scholar
• Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics113, 394–396 (2004).
   PubMed Web of Science ®Google Scholar
• Tin W. Oxygen therapy: 50 years of uncertainty. Pediatrics110, 615–616 (2002).
   PubMed Web of Science ®Google Scholar
• The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics105, 295–310 (2000).
   PubMed Web of Science ®Google Scholar
• Higgins RD, Mendelsohn AL, DeFeo MJ et al. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch. Ophthalmol.116, 601–605 (1998).
   PubMedGoogle Scholar
• Vidaeff AC. Antenatal corticosteroids for fetal maturation in women at risk for preterm delivery. Clin. Perinatol.30(4), 825–840 (2003).
   PubMedGoogle Scholar
• Hellstrom A, Perruzzi C, Ju M et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl Acad. Sci. USA98(10), 5804–5808 (2001).
   PubMed Web of Science ®Google Scholar
• Hellstrom A, Engstrom E, Hard AL et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics112(5), 1016–1020 (2003).
   PubMed Web of Science ®Google Scholar
• Smith LE. IGF-1 and retinopathy of prematurity in the preterm infant. Biol. Neonate88(3), 237–244 (2005).
   PubMedGoogle Scholar
• Pierce EA, Avery RL, Foley ED et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl Acad. Sci. USA92, 905–909 (1995).
   PubMed Web of Science ®Google Scholar
• Shih SC, Ju M, Liu N, Smith LE. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J. Clin. Invest.112, 50–57 (2003).
   PubMed Web of Science ®Google Scholar
• Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov.5, 123–132 (2006).
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat. Med.9, 669–676 (2003).
   PubMed Web of Science ®Google Scholar
• Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br. J. Ophthalmol.90(12), 1542–1547 (2006).
   PubMed Web of Science ®Google Scholar
• McGuire PG, Jones TR, Talarico N, Warren E, Das A. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target. Invest. Ophthalmol. Vis. Sci.44(6), 2736–2742 (2003).
   PubMed Web of Science ®Google Scholar
• Afzal A, Shaw LC, Caballero S et al. Reduction in preretinal neovascularization by ribozymes that cleave the A2B adenosine receptor mRNA. Circ. Res.93(6), 500–516 (2003).
   PubMed Web of Science ®Google Scholar
• Davitt BV, Dobson V, Good WV et al.; Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology112(9), 1564–1568 (2005).
   PubMed Web of Science ®Google Scholar
• Holmstrom M, el Azazi M, Kugelberg U. Ophthalmological long-term follow up of preterm infants: a population based, prospective study of the refraction and its development. Br. J. Ophthalmol.82(11), 1265–1271 (1998).
   PubMed Web of Science ®Google Scholar